Introducing universal ultrasound screening for developmental dysplasia of the hip doubled the treatment rate

Stine F Olsen1, Hans C Blom2, Karen Rosendahl3,4

  • 1Department of Radiology, Vestre Viken Hospital Trust, Drammen, Norway.

Insights

Adding universal ultrasound screening to clinical exams for developmental dysplasia of the hip doubled infant treatment rates. This did not increase late diagnoses in a low-prevalence population.

Area of Science:

  • Pediatrics
  • Orthopedic Surgery
  • Diagnostic Imaging

Background:

  • Developmental dysplasia of the hip (DDH) screening lacks evidence for universal ultrasound's impact.
  • Clinical screening alone may miss cases in low-prevalence populations.

Purpose of the Study:

  • To evaluate the effect of adding ultrasound to clinical screening for DDH.
  • To assess changes in treatment rates, follow-up, and late diagnoses.

Main Methods:

  • A study of 4245 infants (1998-2006) included clinical and ultrasound hip screening within three days of life.
  • Treatment was indicated for positive clinical signs or sonographic dysplasia.
  • Data was compared to a prestudy period (1989-1997) of 3594 infants.

Main Results:

  • The treatment rate for DDH doubled from 0.9% to 2.1% with the addition of ultrasound screening.
  • Follow-up rates remained unchanged at 11%.
  • Late diagnoses remained low, with no cases of surgery or avascular necrosis in the first year.

Conclusions:

  • Universal ultrasound screening, combined with clinical examination, effectively doubles DDH treatment rates.
  • This approach did not negatively impact the low rates of late diagnoses.
Abstract